Mosbrooker Eric
Chief Commercial Officer
Mosbrooker Eric has filed 4 SEC Form 4 filings (8 transaction rows) across 2 companies, including RNAM, RNA, with disclosures dating back to 2025. 3 of those filings fall inside the rolling window. Most recent filing: Feb 27, 2026.
On the most recent filing, Mosbrooker Eric is listed as Chief Commercial Officer at Avidity Biosciences, Inc. Inside the rolling window, Mosbrooker Eric reported no open-market purchases and 1 open-market sale totaling $298K in RNA.
Companies traded
Other insiders at RNAM
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$298K
reported sales (SEC code S)
Companies
2
in the rolling window
Earlier trades
Open-market purchases and sales filed before the rolling 365-day window, kept from the original Form 4 filings.
| Date | Ticker | Type | Value |
|---|---|---|---|
| Sep 3, 2025 | RNA | Sale | $309K |
Frequently asked questions
How many SEC Form 4 filings has Mosbrooker Eric made?
Mosbrooker Eric has filed 4 SEC Form 4 filings (8 transaction rows) across 2 companies, including RNAM, RNA since 2025.
Which companies does Mosbrooker Eric trade?
Mosbrooker Eric has filed SEC Form 4 disclosures for 2 companies, including RNAM, RNA.
When was Mosbrooker Eric's most recent SEC Form 4 filing?
Mosbrooker Eric's most recent SEC Form 4 filing on Tracefour is dated Feb 27, 2026.
What is Mosbrooker Eric's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Mosbrooker Eric is listed as Chief Commercial Officer.
What is Mosbrooker Eric's total buy and sell value in the current window?
Inside the rolling retention window, Mosbrooker Eric bought $0 and sold $298K based on SEC Form 4 filings.
What was Mosbrooker Eric's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 6,562 RNA shares on 2025-10-03, worth $298K, per SEC Form 4 filings.